Business Context and Reporting Period
This Form 8-K is a current report filed by ReShape Lifesciences Inc. (not Vyome Holdings, Inc.) on May 6, 2025. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol RSLS. The report details a material corporate action regarding the company's capital structure.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a notice of a corporate governance event.
Material Changes
- Reverse Stock Split: The Company effected a 1-for-25 reverse stock split of its outstanding common stock.
- Effective Date: The split became effective for trading purposes on May 9, 2025.
- Share Conversion: Every 25 shares of issued and outstanding common stock were converted into one share. Fractional shares were rounded up to the nearest whole share.
- Adjustments to Securities: Proportional adjustments were made to the number of shares issuable and the exercise/conversion prices for outstanding warrants, stock options, and convertible preferred stock.
- Authorized Shares: The split did not reduce the number of authorized shares, thereby increasing the number of shares available for future issuance relative to outstanding shares.
- Voting Rights: The par value and voting rights of the common and preferred stock remain unaltered.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the structural change. The reverse split was approved by stockholders at a special meeting held on April 1, 2025. A press release announcing the split was issued on May 7, 2025.
Investor Verification Checklist
- Verify the new share count and trading price on the Nasdaq Capital Market effective May 9, 2025.
- Confirm the adjusted exercise prices and share quantities for any held options, warrants, or convertible securities.
- Review the Seventh Amendment to the Restated Certificate of Incorporation (Exhibit 3.1) for precise legal terms.
- Note that the company name in the filing is ReShape Lifesciences Inc., not Vyome Holdings, Inc.